Search research articles
Contact Us
Filters
Showing results (101-110 of 625) with videos related to
Page
of 63
Sort By:
JAMA
|
January 13, 1989
Pesticide residue in lanolin
C A Copeland, M A Raebel, S L Wagner
Oncogene
|
November 20, 2012
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
R A Copeland, M P Moyer, V M Richon
The Journal of Chemical Physics
|
August 13, 2005
Vibrational energy transfer in O2(X 3sigma(g)-, upsilon=2,3) + O2 collisions at 330 K
Konstantinos S Kalogerakis, Richard A Copeland, Tom G Slanger
Military Medicine
|
August 10, 2006
Serious mental illness, aging, and utilization patterns among veterans
John E Zeber, Laurel A Copeland, Kyle L Grazier
Nature Reviews. Drug Discovery
|
August 5, 2006
Drug-target residence time and its implications for lead optimization
Robert A Copeland, David L Pompliano, Thomas D Meek
Biophysical Journal
|
August 31, 1999
The second derivative electronic absorption spectrum of cytochrome c oxidase in the Soret region
M P Horvath, R A Copeland, M W Makinen
American Journal of Preventive Medicine
|
November 21, 2015
Child Care Center Characteristics Associated With Preschoolers' Physical Activity
Kristen A Copeland, Jane C Khoury, Heidi J Kalkwarf
Health Education & Behavior : the Official Publication of the Society for Public Health Education
|
September 8, 2009
Health care utilization by older alcohol-using veterans: effects of a brief intervention to reduce at-risk drinking
Laurel A Copeland, Frederic C Blow, Kristen Lawton Barry
Nature Reviews. Drug Discovery
|
September 2, 2009
Protein methyltransferases as a target class for drug discovery
Robert A Copeland, Michael E Solomon, Victoria M Richon
Current Opinion in Chemical Biology
|
July 13, 2010
Targeting epigenetic enzymes for drug discovery
Robert A Copeland, Edward J Olhava, Margaret Porter Scott
Page
of 63
Search research articles
Search
Showing results (101-110 of 625) with videos related to
Sort By:
Page
of 63
JAMA
|
January 13, 1989
Pesticide residue in lanolin
C A Copeland, M A Raebel, S L Wagner
Oncogene
|
November 20, 2012
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics
R A Copeland, M P Moyer, V M Richon
The Journal of Chemical Physics
|
August 13, 2005
Vibrational energy transfer in O2(X 3sigma(g)-, upsilon=2,3) + O2 collisions at 330 K
Konstantinos S Kalogerakis, Richard A Copeland, Tom G Slanger
Military Medicine
|
August 10, 2006
Serious mental illness, aging, and utilization patterns among veterans
John E Zeber, Laurel A Copeland, Kyle L Grazier
Nature Reviews. Drug Discovery
|
August 5, 2006
Drug-target residence time and its implications for lead optimization
Robert A Copeland, David L Pompliano, Thomas D Meek
Biophysical Journal
|
August 31, 1999
The second derivative electronic absorption spectrum of cytochrome c oxidase in the Soret region
M P Horvath, R A Copeland, M W Makinen
American Journal of Preventive Medicine
|
November 21, 2015
Child Care Center Characteristics Associated With Preschoolers' Physical Activity
Kristen A Copeland, Jane C Khoury, Heidi J Kalkwarf
Health Education & Behavior : the Official Publication of the Society for Public Health Education
|
September 8, 2009
Health care utilization by older alcohol-using veterans: effects of a brief intervention to reduce at-risk drinking
Laurel A Copeland, Frederic C Blow, Kristen Lawton Barry
Nature Reviews. Drug Discovery
|
September 2, 2009
Protein methyltransferases as a target class for drug discovery
Robert A Copeland, Michael E Solomon, Victoria M Richon
Current Opinion in Chemical Biology
|
July 13, 2010
Targeting epigenetic enzymes for drug discovery
Robert A Copeland, Edward J Olhava, Margaret Porter Scott
Page
of 63